La Jolla's shares soar after blood pressure drug clears key study

(Reuters) - La Jolla Pharmaceutical Co's shares surged as much as 76.8 percent on Monday after the company said its drug to treat low blood pressure succeeded in a key trial, taking it one step closer to bringing its first drug to market.

Source: Reuters: Health - February 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news